New Frontiers in Alzheimer’s
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
New to Audible Prime Member exclusive:
2 credits with free trial
2 credits with free trial
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.
Buy Now for ₹585.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice.
-
Narrated by:
-
Mack Sanderson
-
Kate Mulligan
-
Erica Sullivan
-
Traber Burns
-
Written by:
-
Scientific American
About this listen
Until recently, one idea has dominated research in treating Alzheimer’s disease: the amyloid hypothesis. Those therapies have repeatedly fallen short, and in this audiobook we take a look at where that hypothesis stands today. We examine recent research into the spectrum of disease causes, including inflammation and immune dysfunction; cutting-edge treatments, including deep-brain stimulation and magnetic resonance - guided focused ultrasound; as well as lifestyle interventions that can help protect from disease.
©2020 Scientific American, a division of Springer Nature America, Inc. (P)2021 Blackstone PublishingWhat listeners say about New Frontiers in Alzheimer’s
Average Customer RatingsOverall
Performance
Story